search
Back to results

Performance Evaluation of the NaviAid™ G-Eye System

Primary Purpose

Colorectal Cancer, Polyp, Adenoma

Status
Completed
Phase
Not Applicable
Locations
International
Study Type
Interventional
Intervention
Group A-Standard Colonoscopy, then NaviAid™ G-Eye procedure
Group B-NaviAid™ G-Eye procedure, then Standard Colonoscopy
Sponsored by
Smart Medical Systems Ltd.
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional diagnostic trial for Colorectal Cancer focused on measuring Colorectal Cancer, Polyp, Adenoma, Detection Rate, Colonoscopy, NaviAid™ G-Eye procedure, NaviAid™ G-Eye system, G-Eye procedure, G-Eye system

Eligibility Criteria

40 Years - undefined (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • The patient is undergoing colonoscopy for screening, for surveillance in follow-up of previous polypectomy or for diagnostic workup;
  • The patient is over 40 years old;
  • The patient must understand and provide written consent for the procedure.

Exclusion Criteria:

  • Subjects with inflammatory bowel disease;
  • Subjects with a personal history of polyposis syndrome;
  • Subjects with suspected chronic stricture potentially precluding complete colonoscopy;
  • Subjects with diverticulitis or toxic megacolon;
  • Subjects with a history of radiation therapy to abdomen or pelvis;
  • Pregnant or lactating female subjects;
  • Subjects who are currently enrolled in another clinical investigation.
  • Subjects with routine oral or parenteral use of anticoagulants
  • Subjects with recent (within the last 3 mounts) coronary ischemia or CVA (stroke)
  • Any patient condition deemed too risky for the study by the investigator

Sites / Locations

  • St. Marienkrankenhaus Frankfurt
  • Hadassah Medical Organization
  • Laniado Hospital
  • Tel Aviv Sourasky Medical Center

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

A-Standard Colonoscopy, G-Eye procedure

B- G-Eye procedure, Standard Colonoscopy

Arm Description

Standard Colonoscopy,G-Eye procedure

G-Eye procedure,Standard Colonoscopy

Outcomes

Primary Outcome Measures

NaviAid™ G-Eye procedure adenoma detection rate compared to the standard colonoscopy procedure adenoma detection rate

Secondary Outcome Measures

Full Information

First Posted
March 6, 2012
Last Updated
April 6, 2014
Sponsor
Smart Medical Systems Ltd.
search

1. Study Identification

Unique Protocol Identification Number
NCT01552200
Brief Title
Performance Evaluation of the NaviAid™ G-Eye System
Official Title
Performance Evaluation of the NaviAid™ G-Eye System
Study Type
Interventional

2. Study Status

Record Verification Date
April 2014
Overall Recruitment Status
Completed
Study Start Date
June 2012 (undefined)
Primary Completion Date
June 2013 (Actual)
Study Completion Date
June 2013 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Smart Medical Systems Ltd.

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
The purpose of this study is to compare the additional diagnostic yield obtained by performing NaviAid™ G-Eye procedure vs. the diagnostic yield obtained by performing standard colonoscopy procedure.
Detailed Description
Colonoscopy is the gold-standard method for CRC screening, as it enables detection and real-time removal of pre-cancerous polyps during the examination. It is well known that lesions are missed during routine colonoscopy.5 major reasons can be detailed for missing polyps during colonoscopy: polyps that are hidden behind folds, polyps that are masked by the colon's topography and natural folds, shallow polyps, unscreened portions of the colon (due to incomplete colonoscopy) and endoscope slippage. The NaviAid™ G-Eye system presents a unique concept that overcomes all 5 items listed above, providing an overall solution to the two endoscopy key challenges of limited detection/treatment yield and limited operation range. The G-Eye endoscope comprises a standard endoscope onto which a unique balloon is permanently integrated, at its bending section. The NaviAid™ G-Eye may be used for performing controlled withdrawal and endoscope stabilization. A major attribute of the NaviAid™ G-Eye system controlled withdrawal technique of the endoscope, with the balloon moderately inflated is to expand and stretch the intestinal lumen during endoscope withdrawal. This is a multicenter, two-arm, randomized, open-label study intended to compare the additional diagnostic yield obtained by performing NaviAid™ G-Eye procedure vs. the diagnostic yield obtained by performing standard colonoscopy procedure. Subjects will be randomized to one of two groups: Group A, the "Study Group," and Group B, the "Control Group." Group A: Subjects will undergo a complete standard colonoscopy as the first procedure. Immediately after the standard colonoscopy procedure, a complete NaviAid™ G-Eye procedure will be performed by the same endoscopist. Group B: Subjects will undergo a complete NaviAid™ G-Eye procedure as the first procedure. Immediately after the NaviAid™ G-Eye procedure, a complete standard colonoscopy will be performed by the same endoscopist.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Colorectal Cancer, Polyp, Adenoma
Keywords
Colorectal Cancer, Polyp, Adenoma, Detection Rate, Colonoscopy, NaviAid™ G-Eye procedure, NaviAid™ G-Eye system, G-Eye procedure, G-Eye system

7. Study Design

Primary Purpose
Diagnostic
Study Phase
Not Applicable
Interventional Study Model
Crossover Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
126 (Actual)

8. Arms, Groups, and Interventions

Arm Title
A-Standard Colonoscopy, G-Eye procedure
Arm Type
Experimental
Arm Description
Standard Colonoscopy,G-Eye procedure
Arm Title
B- G-Eye procedure, Standard Colonoscopy
Arm Type
Active Comparator
Arm Description
G-Eye procedure,Standard Colonoscopy
Intervention Type
Procedure
Intervention Name(s)
Group A-Standard Colonoscopy, then NaviAid™ G-Eye procedure
Intervention Description
Standard Colonoscopy,NaviAid™ G-Eye procedure
Intervention Type
Procedure
Intervention Name(s)
Group B-NaviAid™ G-Eye procedure, then Standard Colonoscopy
Intervention Description
G-Eye procedure, Standard Colonoscopy
Primary Outcome Measure Information:
Title
NaviAid™ G-Eye procedure adenoma detection rate compared to the standard colonoscopy procedure adenoma detection rate
Time Frame
Subjects will be followed during the study period (approximatly 3 hours) and follow up will be done within 48-72 hours following the procedure

10. Eligibility

Sex
All
Minimum Age & Unit of Time
40 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: The patient is undergoing colonoscopy for screening, for surveillance in follow-up of previous polypectomy or for diagnostic workup; The patient is over 40 years old; The patient must understand and provide written consent for the procedure. Exclusion Criteria: Subjects with inflammatory bowel disease; Subjects with a personal history of polyposis syndrome; Subjects with suspected chronic stricture potentially precluding complete colonoscopy; Subjects with diverticulitis or toxic megacolon; Subjects with a history of radiation therapy to abdomen or pelvis; Pregnant or lactating female subjects; Subjects who are currently enrolled in another clinical investigation. Subjects with routine oral or parenteral use of anticoagulants Subjects with recent (within the last 3 mounts) coronary ischemia or CVA (stroke) Any patient condition deemed too risky for the study by the investigator
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Erwin Santo, MD
Organizational Affiliation
Tel-Aviv Sourasky Medical Center
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Beny Shpak, MD
Organizational Affiliation
Laniado Hospital
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Yael Kopelman, MD
Organizational Affiliation
Hadassah Medical Organization
Official's Role
Principal Investigator
Facility Information:
Facility Name
St. Marienkrankenhaus Frankfurt
City
Frankfurt
ZIP/Postal Code
60318
Country
Germany
Facility Name
Hadassah Medical Organization
City
Jerusalem
ZIP/Postal Code
91120
Country
Israel
Facility Name
Laniado Hospital
City
Netanya
ZIP/Postal Code
42150
Country
Israel
Facility Name
Tel Aviv Sourasky Medical Center
City
Tel Aviv
ZIP/Postal Code
64239
Country
Israel

12. IPD Sharing Statement

Citations:
PubMed Identifier
25704662
Citation
Halpern Z, Gross SA, Gralnek IM, Shpak B, Pochapin M, Hoffman A, Mizrahi M, Rochberger YS, Moshkowitz M, Santo E, Melhem A, Grinshpon R, Pfefer J, Kiesslich R. Comparison of adenoma detection and miss rates between a novel balloon colonoscope and standard colonoscopy: a randomized tandem study. Endoscopy. 2015 Mar;47(3):238-44. doi: 10.1055/s-0034-1391437. Epub 2015 Feb 17. Erratum In: Endoscopy. 2015 Apr;47(4):301.
Results Reference
derived

Learn more about this trial

Performance Evaluation of the NaviAid™ G-Eye System

We'll reach out to this number within 24 hrs